The rules for the Annual Price Revision 2026 were published.

‍

Ordinance no. 394/2025/1 of November 14th and Informative Note 132/CD/100.20.200 of November 17th set out the reference countries to be considered for price calculation and the criteria for Annual Price Revision (RAP) of 2026.

‍

The deadlines for RAP 2026 were also defined:

- For non-generic and non-biosimilar medicinal products, new maximum prices must be submitted to INFARMED up to 15th December 2025, which will come into force on 1st January 2026.

- For generic and biosimilar medicinal products, new maximum prices must be submitted to INFARMED up to 15th January 2026, which will come into force on 1st February 2026.

‍

Along with the Informative Note, all the support documentation for RAP 2026 was also published in INFARMED’s website.

‍

Owlpharma can support you in the preparation of Annual Price Revision. For more information, please contact us at owlpharma@owlpharma.pt.

‍